Researchers at the University of Natural Resources and Life Sciences, Vienna, and Institut Teknologi Sumatera, Indonesia, set out to explore the dynamics behind shared micromobility fleet development. By utilizing a system dynamics modeling approach, they examined how fleet size, user demand, regulatory policies, and economic factors interact to shape the success of these systems.

The 8^th Digital Olfaction Society World Congress will bring together global pioneers in science, technology, and industry to showcase groundbreaking advancements in the field of digital olfaction. Held at the AP Tokyo Yaesu Dori Convention Center on December 5-6 2024, the event will highlight cutting-edge innovations and transformative applications of scent digitization technologies.

A new method to increase fusion-fuel efficiency would involve aligning the quantum spin of deuterium and tritium and changing the mix of the two fuels. The approach could boost tritium-burn efficiency by up to 10 times, reducing tritium needs and lowering fusion system costs. The technique could lead to safer, more compact fusion systems, making fusion energy more practical and affordable.

The IRB Barcelona spin-off Gate2Brain, a cutting-edge technology platform focused on enhancing drug delivery to the brain, has reached a major milestone in the fight against pediatric brain tumors by obtaining Orphan Drug Designation (ODD) from the European Medicines Agency (EMA) for its innovative product, G2B-002.

This designation recognizes G2B-002 as a potential treatment for a rare and severe disease, specifically granted to drugs aimed at conditions affecting fewer than 5 in 10,000 people in the European Union, and which offer significant advantages over limited or non-existent alternatives.

Researchers described a promising new approach for using gene therapy to treat sickle cell disease in the peer-reviewed journal Human Gene Therapy. To improve the efficacy of gene therapy when using anti-sickling beta globin gene transfer, they added cyclosporin (CsH) to increase transduction by inhibiting lentiviral restriction factors.